Co-Diagnostics says new FDA policy to help expand use of COVID-19 test

Co-Diagnostics Inc said on Tuesday the U.S. Food and Drug Administration's new policy to expand the availability of COVID-19 tests would allow the medical test maker's tests to be distributed to a wide array of U.S. labs.